biotechnology
Biotech and pharma company sign licence agreement in field of veterinary diagnostics
Biotechnology company, Leukocare, and pharma company, Boehringer Ingelheim, have entered into a licence agreement in the field of veterinary diagnostics. more
Shire collaborates with NIBRT for professional training development
Biotechnology company, Shire, has announced a professional training development collaboration with the National Institute of Bioprocessing Research and Training (NIBRT) in Dublin, Ireland. more
Q BioMed files for FDA approval of non-opioid manufacturing facility
Commercial stage biotechnology acceleration development company, Q BioMed, and Bio-Nucleonics, licensor of Strontium-89 Chloride, have filed for regulatory approval of a new manufacturing facility by the US Food and Drug Administration (FDA). more
FDA accepts IND application for UK biotech’s antibacterial drug candidate
Clinical stage biotechnology company, Destiny Pharma, has announced that the US Food and Drug Administration (FDA) has accepted its investigational new drug application (IND) for its lead clinical drug candidate, XF-73. more
CASE STUDY: Better safe than sorry when handling sensitive products
This case study details Schubert-Pharma’s automated solution for a small-component packaging task. more
Biotech receives orphan drug designation from FDA for immunotherapy
Biotechnology company, GamaMabs Pharma, has received orphan drug designation from the US Food and Drug Administration (FDA) for its lead compound GM102 to treat advanced ovarian cancers. more
UK biotech wins further funding from Innovate UK for Zika vaccine
UK-based biotechnology company, Stabilitech Biopharma, has received further funding from Innovate UK to develop its oral Zika virus vaccine so that it is first-in-human ready by 2020. more
Biotech chooses FlexFactory for new Chinese facility
Biotechnology company, Clover Biopharmaceuticals, has announced its choice of biomanufacturing platform as being GE Healthcare’s FlexFactory for its new facility located in Changxing, China. more
Biotech raises $58 million in funding to advance drug programmes
Pandion Therapeutics, a biotechnology company, has raised $58 million at the completion of its Series A financing round, which will be used to advance its initial drug programmes for autoimmune and inflammatory diseases more
Combination strategy may offer longer term benefits in cancer, notes research
A new strategy to tackle the issue of long-term treatment efficacy in cancer patients has been developed by researchers from the Netherlands Cancer Institute in collaboration with international biotechnology company, Genmab. more
Biotech raises funds to help produce phage therapies for bacterial infections
Biotechnology company, Pherecydes Pharma, has raised €8.7 million in a Series B round of funding, which it plans to use to support the production of phages for compassionate use in accordance with good manufacturing practuces (GMP). more
New companion diagnostic development agreement signed for novel oncology compound
Innovative molecular diagnostics company, Biocartis Group, and biotechnology company, Amgen, have signed a new companion diagnostic (CDx) development agreement for a novel oncology compound. more
Pfizer & Imcyse form research collaboration targeting rheumatoid arthritis
A research collaboration for the development of a specific modified peptide targeting rheumatoid arthritis (RA) has been formed between Pfizer and Imcyse — a biotech company developing specific therapies for the treatment of severe chronic diseases. more
Clinical update on immunotherapy for breast cancer provided by BriaCell
An immune-oncology focused biotechnology company, BriaCell, has provided a clinical update on its lead immunotherapy drug for advanced breast cancer. more
VirionHealth receives funding for development of a new class of biological antivirals
Biotechnology company, VirionHealth, has won non-dilutive funding from the US Defense Advanced Research Projects Agency (DARPA) to support development of its new class of biological antivirals. more
Shire files first submission to FDA for new plasma manufacturing facility
Global biotechnology company, Shire, has filed its first submission to the US Food and Drug Administration (FDA) for a new plasma manufacturing facility in Covington, Georgia, to support growth in its immunology franchise. more
FDA approves Phase Ib/IIa study of GNS561 for treatment of liver cancer
Genoscience Pharma has announced that initiation of a Phase Ib/IIa study of its most advanced compound, GNS561, for the treatment of patients with advanced hepatocarcinoma (HCC), has received approval from the US Food and Drug Administration (FDA). more
Lonza and MEE grant exclusive licences to biotech for gene therapy platform
Lonza and Massachusetts Eye and Ear (MEE) have granted Akouos (a new biotechnology company) licences for exclusive rights to the ancestral adeno-associated viral vectors (Anc-AAV) gene therapy platform for all hearing and balance disorders. more
Phillips-Medisize & Dance Biopharm working on connected insulin inhaler
Phillips-Medisize has entered into an agreement with biotechnology company Dance Biopharm to develop a connected insulin inhaler. more
Biocartis and Amgen sign CDx development agreement for biomarker tests
Molecular diagnostics company, Biocartis, has signed a companion diagnostic (CDx) development agreement with biotechnology company, Amgen, for the Idylla RAS biomarker tests. more
